{"product_id":"concept-and-practice-of-therapeutic-teams-proceedings-of-the-11th-european-symposium-on-clinical-pharmacy-brussels-1982-paperback-9780521279178","title":"Concept and Practice of Therapeutic Teams; Proceedings of the 11th European Symposium on Clinical Pharmacy, Brussels 1982 (Paperback) 9780521279178","description":"\u003cfont face=\"Georgia\"\u003e\r\n\u003cp\u003e\u003cfont size=\"6\"\u003eConcept and Practice of Therapeutic Teams\u003c\/font\u003e\u003cbr\u003e\r\n\u003cfont size=\"5\"\u003eProceedings of the 11th European Symposium on Clinical Pharmacy, Brussels 1982\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cem\u003eThis 1983 book reports the proceedings of the eleventh European symposium on clinical pharmacy which was held in Brussels in October 1982.\u003c\/em\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003cp\u003e\u003cfont size=\"4\"\u003eH. de Clercq (Edited by), J. W. Poston (Edited by), Joaquin Bonal (Edited by)\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e9780521279178, Cambridge University Press\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePaperback, published 9 June 2011\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003e266 pages\u003cbr\u003e22.9 x 15.2 x 1.5 cm, 0.4 kg\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\r\n\r\n\r\n\u003cp align=\"justify\"\u003e\u003cstrong\u003e\u003cfont size=\"3\"\u003eThis 1983 book reports the proceedings of the eleventh European symposium on clinical pharmacy which was held in Brussels in October 1982. The theme of the symposium was the concept of the therapeutic team and the relative contributions and responsibilities of pharmacists, nurses and physicians to the planning and implementation of drug treatment regimens. The first section of the volume provides an introduction to the concept of the therapeutic team and reflects the views several medical professionals. The later sections cover the practice of the therapeutic team in parenteral nutrition, oncology, dermatology, epilepsy, internal medicine, nuclear medicine and drug selection. Not only did this book review achievements and experiences in clinical pharmacy, but it also looked towards the future of clinical pharmacy development in Europe. It will still be of significant interest to clinical pharmacy specialists today.\u003c\/font\u003e\u003c\/strong\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003ePreface\u003cbr\u003e Part I. Introduction: 1. Introductory remarks\u003cbr\u003e Part II. The Concept of the Theraputic Team: 2. The concept of the therapeutic team\u003cbr\u003e 3. The view of a pharmacist\u003cbr\u003e 4. The view of a physician\u003cbr\u003e 5. The view of a nurse\u003cbr\u003e 6. The view of the clinical pharmacologist\u003cbr\u003e 7. The view of an academic\u003cbr\u003e Part III. Practice of the Therapeutic Team: Parenteral Nutrition: 8. Parenteral nutrition - the team approach in a general hospital\u003cbr\u003e 9. Long-term follow-up in total parenteral nutrition\u003cbr\u003e 10. Total parenteral nutrition of children at the State University Hospital of Copenhagen\u003cbr\u003e 11. Compatibility of two different fat emulsions with amino-acids, carbohydrate and electrolytes in parenteral nutrition mixtures\u003cbr\u003e 12. Esophagus cancer and parenteral nutrition: postoperative complications and P. N. I. relationship. Preliminary study\u003cbr\u003e Part IV. Oncology: 13. Central nervous system prohylaxis of acute lymphoblastic leukemia with methotrexate\u003cbr\u003e 14. The treatment protocols of acute lymphoblastic leukemia in children\u003cbr\u003e 15. Guidelines for the safe handling of minibags\u003cbr\u003e 16. Centralization of preparation of cytotoxic drugs in the central pharmacy: one year of experience\u003cbr\u003e 17. Progress in the management of high dose methotrexate\u003cbr\u003e 18. Parmacokinetics of cytosine arabinoside in leukemic patients with normal and impaired hepatic functions, preliminary results\u003cbr\u003e PartV. Dermatology: 19. The operation of a therapeutic team in dermatology\u003cbr\u003e Part VI. Epilepsy: 20. Team treatment of epilepsy\u003cbr\u003e 21. Practices of the therapeutic team in epilepsy\u003cbr\u003e 22. Interdisciplinary approach to the treatment of epilepsy\u003cbr\u003e 23. The role of clinical pharmacist in the monitoring of antiepileptic therapy in clinics with ambulant patients, our experience with 45 patients\u003cbr\u003e Part VII. Internal Medicine - Rheumatology: 24. An approach to the therapeutic strategy in rheumatoid arthritis. Adverse reactions to penicillamine-like drugs used in the treatment of rheumatoid arthritis\u003cbr\u003e Part VIII. Nuclear Medicine: 25. The nuclear medicine team\u003cbr\u003e 26. Practice of the nuclear medicine therapeutic team: the role of the physician\u003cbr\u003e 27. Practice of the nuclear medicine therapeutic team: the role of the physicist\u003cbr\u003e 28. Practice of the nuclear medicine therapeutic team: the role of the radiotherapist\u003cbr\u003e Part IX. Drug Selection: 29. Collaboration in drug selection - preparing the London Hospital Formulary 1982 - guide to the prescribing of medicines: introduction\u003cbr\u003e 30. A clinician's view on the team approach to drug selection\u003cbr\u003e 31. A pharmacists view on the team approach to drug selection\u003cbr\u003e 32. Conclusion\u003cbr\u003e 33. Restrictive formulary management with consequences for the treatment of individual patients\u003cbr\u003e 34. Changes in patterns of analgesic use\u003cbr\u003e Part X. Pharmacokinetics, Dialysis, I. V. Therapy: 35. Clinical pharmacy improvement and interrelation with therapeutci team\u003cbr\u003e 36. Clinical pharmacist participation in a clinical trial - treatment of congestive heart failure\u003cbr\u003e 37. Metronidazole plasma levels after I. V. and rectal administration\u003cbr\u003e 38. Individual factors influencing aminoglycoside serum levels\u003cbr\u003e 39. Monitoring theophylline plasma levels\u003cbr\u003e 40. Comparison of four pharmacokinetic methods for individualizing phenytoin dosage\u003cbr\u003e 41. Use of a calculator program for individualized estimation of pheyoin kinetic parameters by a least-squares technique\u003cbr\u003e 42. On the importance of regular Al determination in patients on regular hemodialysis (RHD)\u003cbr\u003e 43. Manufacture of dialysis concentrate at the level of a hospital\u003cbr\u003e 44. Hospital preparation of injectable drugs by means of a multi-additive pump\u003cbr\u003e 45. How to detect physico-chemical incompatabilities in I. V. admixtures\u003cbr\u003e 46. Preparation of an enema containing metaminosalicylic acid\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\u003cp\u003e\u003cfont size=\"3\"\u003eSubject Areas: Medicine: general issues [\u003ca title=\"See our other books on Medicine: general issues\" href=\"https:\/\/freshlyprintedbooks.co.uk\/search?q=%22Medicine:%20general%20issues%20%5BMB%5D%22\"\u003eMB\u003c\/a\u003e]\u003c\/font\u003e\u003c\/p\u003e\r\n\r\n\r\n\u003c\/font\u003e","brand":"Cambridge University Press","offers":[{"title":"Default Title","offer_id":46006971007256,"sku":"9780521279178","price":35.99,"currency_code":"GBP","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0730\/2037\/5320\/products\/9780521279178i_903338db-50e9-4d6e-ae33-1a6b8039cf41.jpg?v=1691374415","url":"https:\/\/freshlyprintedbooks.co.uk\/products\/concept-and-practice-of-therapeutic-teams-proceedings-of-the-11th-european-symposium-on-clinical-pharmacy-brussels-1982-paperback-9780521279178","provider":"Freshly Printed Books","version":"1.0","type":"link"}